Samsung Hits an All-Time High. Guess Who Else Is Winning.
Invest to Glow: A Not-Very-Serious Theory About Where Money Goes
Have you checked Samsung Electronics lately?
The 52-week low was ₩52,500. It's now trading above ₩216,000. All-time high territory. Which means anyone who held through the lows — whether they averaged down or just held on — is sitting on some very real gains right now.
So here's the question I keep thinking about: where does all that money actually go?
Over 10 Million People Own Samsung Stock
Samsung Electronics has more than 10 million individual shareholders. In a country of 51 million, that's roughly 1 in 5 people. This isn't just a company — it's a national financial event whenever it moves.
When Samsung goes up, an enormous number of people's account balances swell at the same time. And I genuinely keep wondering: what happens to that money?
If You Have Big Money: Real Estate, Travel, a New Car
If your gains are in the tens of millions, the options open up. Top up an apartment deposit. Book that Europe trip. Upgrade the car. Or maybe just rotate back into KOSPI — which could be exactly what pushes it toward 10,000. Or into safe havens like gold and the dollar. Or Bitcoin — because of course some people will just go full crypto again.
If You Have Money Like Me: Skin, Aesthetics, Wellness
But for the average retail investor holding 100–200 shares — the gains are real, but not life-changing. Too small for real estate, too satisfying to just leave sitting there. And that's where a very specific psychology kicks in.
"I should do something with this."
- ₩500K gain → "Rejuran. I've been meaning to do it anyway."
- ₩1M gain → "Finally booking that Ulthera I keep putting off."
- ₩2M gain → "Ulthera + filler combo. And while I'm at it, let me ask about Re2O."
I'm only half joking. And I doubt I'm the only one who thinks this way.
But Does Everyone Else Do This Too?
Anecdotally, it feels like the "I just started going to a dermatologist" conversations tend to cluster around the same period as good market conditions. But honestly — is that a KOSPI thing, or just a spring thing? I genuinely don't know ㅋㅋ
The real question I keep coming back to: when gains land in 10 million people's hands simultaneously — where does it actually flow? Real estate? Crypto? Safe assets? Consumption? Or does it just become fuel for KOSPI to keep climbing?
If even a fraction of that ends up as beauty and wellness spending — maybe that matters for aesthetics biotech stocks. Or maybe it doesn't. I don't have the answer.
I'm just watching the flow — and genuinely curious where it lands. 🤍
My Take
Honestly — I think aesthetics biotech has already run too hard at this point. And right now the money flow feels like it's moving toward space, solar, and semiconductors anyway.
That said, I'm not done with healthcare entirely. What I'm actually more interested in is therapeutic biotech — real treatments, not just aesthetics. The logic is simple: demand for health is only going in one direction. The global success of drugs like Wegovy and Mounjaro is part of that story, and as populations age, the appetite for things that genuinely change quality of life — not just appearance — is going to keep growing.
Beauty treatment trends are cyclical by nature. Rejuran was the moment, now Re2O is having its moment, and something else will come after that. So my approach is: when I notice the next "wait, everyone's suddenly doing this" treatment, that's when I'll start paying attention to the related names. Right now, I don't think we're there yet.
Check Your Glow Level
Holding Samsung? How much are you up?
→ Check your Invest to Glow tracker and see what your gains unlock
→ We'll tell you exactly which treatments are now within reach 😄
💉 Ready to book? Find clinics on KBeauty Finder →